Diamyd Medical AB Expands its Scientific Advisory Board

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Diamyd Medical (STO:DMYD-B) recently acquired exclusive rights relating to the therapeutic use of GABA for the treatment of diabetes and other inflammation-related conditions. The Company is now expanding its Scientific and Medical Advisory Board with three internationally leading experts on GABA and diabetes: Dr. Bryndis Birnir, Dr. Brooke Ligon, and Dr. Qinghua Wang.

Help employers find you! Check out all the jobs and post your resume.

Back to news